Jovana Novaković

Jovana Novaković is an Assistant Professor at the Department of Pharmaceutical Biotechnology, Faculty of Medical Sciences, University of Kragujevac. She holds a PhD in Medical Sciences (2019) and has extensive postgraduate qualifications in Medicinal Biochemistry and Pharmacy. Her research focuses on cardiovascular physiology, pharmaceutical biotechnology, and the role of oxidative stress in metabolic disorders. She has published over 55 peer-reviewed articles in SCI-indexed journals and received four major awards for her contributions to cardiovascular research.

Education:

• PhD in Medical Sciences, Faculty of Medical Sciences, University of Kragujevac (2015–2019)
• Master of Pharmacy, Faculty of Medical Sciences, University of Kragujevac (2010–2015)
• Specialist Studies in Medicinal Biochemistry, Faculty of Medical Sciences, University of Kragujevac (2018)

Research Interests: Her work explores cardioprotective agents (e.g., diallyl trisulfide), mechanisms of ischemia-reperfusion injury, and the impact of metabolic syndrome on cardiac function. She investigates natural products (e.g., Melissa officinalis) and synthetic compounds for their anti-inflammatory and antioxidant properties. Her studies often involve animal models to evaluate drug efficacy and toxicity.

Awards:

• Travel Award for Best Young Scientist (Banja Luka, 2021)
• Gary Lopaschuk Award (International Academy of Cardiovascular Sciences, 2019)
• Travel Award (International Academy of Cardiovascular Sciences, 2019)
• Young Investigator Award (Smolenice, Bratislava, 2018)

Advising & Grants: Novaković collaborates on projects involving drug development and cardiac protection. Her team's work has been published in journals like International Journal of Molecular Science and BIOFACTORS. She participates in international conferences, presenting findings on topics like perfluorocarbon-based blood substitutes and GLP-1 receptor agonists.

Labs & Teams: She is part of the Laboratory for Cardiovascular Physiology at the Faculty of Medical Sciences, contributing to interdisciplinary research on heart failure and metabolic disease intersections.